慢性丙型肝炎基因型 1 复发的临床试验
总计1187个结果
-
Peking University First Hospital招聘中
-
MTmedical Institute of HealthThe University of Texas Health Science Center at San Antonio; BioMonde Preparations Limited未知
-
Palo Alto Veterans Institute for ResearchHoffmann-La Roche完全的
-
AbbVieIST GmbH, Germany完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC完全的艾滋病毒感染 | 丙型肝炎 | 慢性丙型肝炎
-
Gilead Sciences完全的慢性基因型 1a 或 1b HCV 感染美国, 加拿大, 波多黎各
-
National Institute of Diabetes and Digestive and...National Cancer Institute (NCI); National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Minority Health and Health Disparities (NIMHD) 和其他合作者完全的
-
Atea Pharmaceuticals, Inc.撤销丙型肝炎病毒感染 | 丙型肝炎 | 丙型肝炎,慢性 | 慢性丙型肝炎 | 丙肝病毒感染比利时
-
Atea Pharmaceuticals, Inc.完全的
-
Gilead Sciences完全的
-
Universidade Federal do Rio de JaneiroCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Oswaldo Cruz Foundation; Financiadora... 和其他合作者未知
-
University of FloridaPatient-Centered Outcomes Research Institute; Merck Sharp & Dohme LLC; AbbVie完全的
-
Merck Sharp & Dohme LLC完全的
-
Changi General HospitalNational University Hospital, Singapore完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC完全的
-
Janssen R&D Ireland完全的
-
Association HGE CHU Bordeaux SudUniversity Hospital, Bordeaux完全的
-
Bristol-Myers Squibb完全的
-
Bristol-Myers SquibbPharmasset完全的
-
Biocad完全的
-
Janssen R&D IrelandGilead Sciences完全的
-
Merck Sharp & Dohme LLC完全的
-
Centre hospitalier de l'Université de Montréal...Hoffmann-La Roche; Centre de Recherche du Centre Hospitalier de l'Université de Montréal完全的
-
Third Affiliated Hospital, Sun Yat-Sen University未知
-
Peregrine Pharmaceuticals完全的
-
University of BernRoche Pharma AG; University of Lausanne; University of Basel; Cantonal Hospital of St. Gallen; Waid...完全的
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Bristol-Myers Squibb完全的
-
AbbVieIST GmbH, Germany完全的
-
Hospital Carlos III, Madrid完全的